Literature DB >> 19245828

Epigenetics, oxidative stress, and Alzheimer disease.

Nasser H Zawia1, Debomoy K Lahiri, Fernando Cardozo-Pelaez.   

Abstract

Alzheimer disease (AD) is a progressive neurodegenerative disorder whose clinical manifestations appear in old age. The sporadic nature of 90% of AD cases, the differential susceptibility to and course of the illness, as well as the late age onset of the disease suggest that epigenetic and environmental components play a role in the etiology of late-onset AD. Animal exposure studies demonstrated that AD may begin early in life and may involve an interplay between the environment, epigenetics, and oxidative stress. Early life exposure of rodents and primates to the xenobiotic metal lead (Pb) enhanced the expression of genes associated with AD, repressed the expression of others, and increased the burden of oxidative DNA damage in the aged brain. Epigenetic mechanisms that control gene expression and promote the accumulation of oxidative DNA damage are mediated through alterations in the methylation or oxidation of CpG dinucleotides. We found that environmental influences occurring during brain development inhibit DNA-methyltransferases, thus hypomethylating promoters of genes associated with AD such as the beta-amyloid precursor protein (APP). This early life imprint was sustained and triggered later in life to increase the levels of APP and amyloid-beta (Abeta). Increased Abeta levels promoted the production of reactive oxygen species, which damage DNA and accelerate neurodegenerative events. Whereas AD-associated genes were overexpressed late in life, others were repressed, suggesting that these early life perturbations result in hypomethylation as well as hypermethylation of genes. The hypermethylated genes are rendered susceptible to Abeta-enhanced oxidative DNA damage because methylcytosines restrict repair of adjacent hydroxyguanosines. Although the conditions leading to early life hypo- or hypermethylation of specific genes are not known, these changes can have an impact on gene expression and imprint susceptibility to oxidative DNA damage in the aged brain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19245828      PMCID: PMC2673453          DOI: 10.1016/j.freeradbiomed.2009.02.006

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  111 in total

Review 1.  Factors contributing to the outcome of oxidative damage to nucleic acids.

Authors:  Mark D Evans; Marcus S Cooke
Journal:  Bioessays       Date:  2004-05       Impact factor: 4.345

2.  ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein.

Authors:  Demian F Obregon; Kavon Rezai-Zadeh; Yun Bai; Nan Sun; Huayan Hou; Jared Ehrhart; Jin Zeng; Takashi Mori; Gary W Arendash; Doug Shytle; Terrence Town; Jun Tan
Journal:  J Biol Chem       Date:  2006-04-19       Impact factor: 5.157

3.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins.

Authors:  M Gatz; N L Pedersen; S Berg; B Johansson; K Johansson; J A Mortimer; S F Posner; M Viitanen; B Winblad; A Ahlbom
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1997-03       Impact factor: 6.053

4.  Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease.

Authors:  D J Selkoe; C R Abraham; M B Podlisny; L K Duffy
Journal:  J Neurochem       Date:  1986-06       Impact factor: 5.372

5.  Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor.

Authors:  C Haass; A Y Hung; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1994-07-01       Impact factor: 5.157

6.  A mammalian protein with specific demethylase activity for mCpG DNA.

Authors:  S K Bhattacharya; S Ramchandani; N Cervoni; M Szyf
Journal:  Nature       Date:  1999-02-18       Impact factor: 49.962

Review 7.  The neurobiology of Rett syndrome.

Authors:  Schahram Akbarian
Journal:  Neuroscientist       Date:  2003-02       Impact factor: 7.519

Review 8.  Pharmacogenomics in Alzheimer's disease.

Authors:  Ramón Cacabelos
Journal:  Methods Mol Biol       Date:  2008

9.  The prospective role of abnormal methyl metabolism in cadmium toxicity.

Authors:  Lionel A Poirier; Tatyana I Vlasova
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

10.  Identification and characterization of OGG1 mutations in patients with Alzheimer's disease.

Authors:  Guogen Mao; Xiaoyu Pan; Bei-Bei Zhu; Yanbin Zhang; Fenghua Yuan; Jian Huang; Mark A Lovell; Maxwell P Lee; William R Markesbery; Guo-Min Li; Liya Gu
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

View more
  101 in total

Review 1.  Stress and the epigenetic landscape: a link to the pathobiology of human diseases?

Authors:  Sarah E Johnstone; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2010-10-05       Impact factor: 53.242

Review 2.  Effects of micronutrients on DNA repair.

Authors:  Andrew R Collins; Amaya Azqueta; Sabine A S Langie
Journal:  Eur J Nutr       Date:  2012-02-24       Impact factor: 5.614

3.  S. choloroleuca, S. mirzayanii and S. santolinifolia protect PC12 cells from H(2)O (2)-induced apoptosis by blocking the intrinsic pathway.

Authors:  Shabnam Zeighamy Alamdary; Fariba Khodagholi; Fatemeh Shaerzadeh; Niloufar Ansari; Ali Sonboli; Solaleh Khoramian Tusi
Journal:  Cytotechnology       Date:  2011-12-31       Impact factor: 2.058

4.  Positive argument for debate in J Neural Transmission: Alzheimer's disease: are we intervening too late? Yes, by years if not decades.

Authors:  Thomas B Shea; Ruth Remington
Journal:  J Neural Transm (Vienna)       Date:  2012-07-11       Impact factor: 3.575

Review 5.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 6.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

7.  Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.

Authors:  Biswadeep Das; Sriya Priyadarshini Dash; Swabhiman Mohanty; Paritosh Patel
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island.

Authors:  Biju Bhargavan; Bhavana Chhunchha; Nigar Fatma; Eri Kubo; Anil Kumar; Dhirendra P Singh
Journal:  Epigenetics       Date:  2013-02-05       Impact factor: 4.528

Review 9.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

10.  Gene × environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS).

Authors:  Debomoy K Lahiri; Bryan Maloney
Journal:  Epigenomics       Date:  2012-12       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.